Skip to main content
You're browsing a read-only preview with shortened excerpts. Unlock full access

Research paper preview

Cumulus Neuroscience Announces Publication in Scientific Reports Demonstrating NeuLogiq Platform's Feasibility for At-Home Cognitive Assessment in ALS and FTD

PR Newswire · August 18, 2026

Preview

Cumulus Neuroscience has announced the publication of the CNS-102 study results in Scientific Reports, demonstrating the feasibility and usability of its NeuLogiq Platform for at-home, multimodal cognitive assessment in individuals with ALS and FTD. The…

The complete summary, “why it matters” analysis and the original source link are available to members.

alsftdat-home-monitoringcognitive-assessmenteeg